These studies are designed to determine how fatty acids (FFA) stimulate beta-cell compensation early in obesity and yet cause dysfunction and death of compensated beta-cells and NIDDM late in obesity. We have found that PPARalpha serves as the FFA """"""""receptor"""""""" in islets. Compensatory hyperinsulinemia induced by elevations of FFA can be duplicated in vitro by the PPARalpha ligands, clofibrate (CF) plus 9-cis retinoic acid (RA). ZDF rats are unable to compensate for high levels of fatty acids, PPARalpha is markedly reduced in their islets and CF/RA has no effect. Fat accumulates in their islets and ultimately causes apoptosis of beta cells and diabetes. To prove this, we will over-express PPARalpha in beta cells of ZDF rats and determine if this rescues beta-cells from the cytotoxic effects of fatty acids. To determine if the low PPARalpha is secondary to the OB-R receptor mutation, PPARalpha mRNA will be quantified in islets made to over-express wild type OBR. Finally, we will assess the effects of normalizing PPARalpha expression on apoptogenic effects of FFA and on reducing the flux of FFA into ceramide and DAG, key signals in the apoptotic pathway. The studies should indicate the mechanisms by which FFA cause compensatory changes in beta-cells in the early years of obesity but cause dysfunction apoptosis of beta-cells, and diabetes, in the late years.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK002700-42
Application #
6329261
Study Section
Nutrition Study Section (NTN)
Program Officer
Laughlin, Maren R
Project Start
1977-12-01
Project End
2001-11-30
Budget Start
2001-01-08
Budget End
2001-11-30
Support Year
42
Fiscal Year
2001
Total Cost
$292,632
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Unger, Roger H; Scherer, Philipp E (2010) Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 21:345-52
Lee, Y; Lingvay, I; Szczepaniak, L S et al. (2010) Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond) 34:396-400
Yu, Xinxin; Park, Byung-Hyun; Wang, May-Yun et al. (2008) Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A 105:14070-5
Unger, Roger H (2008) Noninvasive tracking of gene expression by reporter transgene imaging. Proc Natl Acad Sci U S A 105:12641-2
Lee, Y; Hirose, H; Zhou, Y T et al. (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46:408-13
Zhou, Y T; Shimabukuro, M; Koyama, K et al. (1997) Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci U S A 94:6386-90